News
05.25.19

Ocular Science Launches Two Affiliates to Focus on Compounding and Biologic Sectors

Ocular Science launches two affiliates to focus on compounding and biologic sectors of ophthalmic market.

05.20.19

ASCRS FDA Committee Member Speaks on Access to Compounded Drugs

ASCRS FDA committee member Damien Goldberg, MD, urges FDA to allow access to compounded drugs from traditional compounders without a patient-specific prescription.